Biomed Chromatogr. 2026 Nov;40(11):e70641. doi: 10.1002/bmc.70641.
ABSTRACT
Yangxin Dingji Capsules (YXDJ), derived from Zhigancao Decoction, are used clinically for arrhythmia. Four D101 macroporous-resin purification procedures involving different Asini Corii Colla incorporation modes and elution solvents were compared; the co-decoction procedures additionally included centrifugation and filtration before resin purification. The unpurified preparation and four purified preparations were characterized by UPLC-Q-TOF-MS/MS and evaluated in a barium chloride-induced rat arrhythmia model using electrocardiographic, biochemical, and histopathological indicators. Fifty-five constituents were tentatively identified. The 60% ethanol-eluted preparations CF1 and CF3 retained 52 and 51 constituents, respectively, whereas the water-eluted preparations CF2 and CF4 retained 21 and 14. CF1 showed the highest Pearson correlation with YXDJ among the purified preparations (r = 0.520), while CF3 had the highest five-indicator comprehensive pharmacodynamic score among the purified preparations (CPS5 = 3.540); unpurified YXDJ scored 3.827. Compared with the model group, CF3 significantly increased heart rate, shortened QRS duration, reduced serum lactate dehydrogenase, and increased Na+/K+-ATPase activity. Exploratory one-component partial least-squares variable-importance and gray relational analyses generated a provisional list of 12 constituents for subsequent targeted quantification and pharmacological verification.
PMID:42867275 | DOI:10.1002/bmc.70641